Diaceutics PLC (DXRX) — Cash Flow Quality Index
Diaceutics PLC (DXRX) has a Cash Flow Quality Index of -0.57x as of December 2024. Operating cash flow of GBX-501.00K is below net income of GBX881.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Diaceutics PLC (DXRX) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Diaceutics PLC Cash Flow Quality Index (2016–2022)
Historical Cash Flow Quality Index for Diaceutics PLC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Diaceutics PLC to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Diaceutics PLC (2016–2022)
Year-by-year earnings quality comparison for Diaceutics PLC. For live market cap and the full company financial profile, see Diaceutics PLC market capitalisation.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 7.04x | GBX5.10 Million | GBX724.00K | ▲ +592.8% |
| 2021 | 1.02x | GBX570.00K | GBX561.00K | ▲ +5.6% |
| 2020 | 0.96x | GBX253.00K | GBX263.00K | ▲ +161.0% |
| 2019 | -1.58x | GBX-627.05K | GBX397.88K | ▼ -4.5% |
| 2018 | -1.51x | GBX-954.04K | GBX632.31K | ▼ -177.2% |
| 2017 | 1.95x | GBX1.53 Million | GBX784.86K | ▲ +127.7% |
| 2016 | 0.86x | GBX674.01K | GBX784.98K | — |